Wolverine Trading’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-57,100	Closed	-$98K	–	5639
2022 Q2	$98K	Sell	57,100 -4,200	-7%	-$6.2K	﹤0.01%	3855
2022 Q1	$101K	Sell	61,300 -8,400	-12%	-$16.5K	﹤0.01%	4822
2021 Q4	$199K	Buy	69,700 +100	+0.1%	+$370	﹤0.01%	4729
2021 Q3	$315K	Sell	69,600 -54,800	-44%	-$264K	﹤0.01%	4634
2021 Q2	$728K	Buy	124,400 +1,100	+0.9%	+$6.45K	﹤0.01%	3184
2021 Q1	$836K	Buy	123,300 +9,000	+8%	+$60.3K	﹤0.01%	3000
2020 Q4	$562K	Buy	114,300 +8,300	+8%	+$42K	﹤0.01%	3037
2020 Q3	$630K	Buy	106,000 +35,700	+51%	+$214K	﹤0.01%	2559
2020 Q2	$494K	Buy	+70,300	New	+$532K	﹤0.01%	2741
2019 Q4	–	Sell	-52,500	Closed	-$210K	–	5404
2019 Q3	$210K	Sell	52,500 -22,400	-30%	-$181K	﹤0.01%	3525
2019 Q2	$1.11M	Buy	74,900 +28,700	+62%	+$519K	﹤0.01%	1950
2019 Q1	$1.15M	Sell	46,200 -5,800	-11%	-$145K	﹤0.01%	1947
2018 Q4	$934K	Sell	52,000 -13,300	-20%	-$272K	﹤0.01%	2033
2018 Q3	$1.92M	Buy	65,300 +34,100	+109%	+$1.32M	﹤0.01%	1713
2018 Q2	$1.65M	Hold	31,200	–	–	﹤0.01%	1766
2018 Q1	$1.65M	Sell	31,200 -5,700	-15%	-$333K	﹤0.01%	1766
2017 Q4	$2.51M	Sell	36,900 -5,100	-12%	-$357K	0.01%	1361
2017 Q3	$3.46M	Sell	42,000 -21,000	-33%	-$1.66M	0.01%	991
2017 Q2	$5.8M	Sell	63,000 -24,900	-28%	-$1.52M	0.03%	596
2017 Q1	$5.52M	Buy	+87,900	New	+$5.34M	0.03%	601
2016 Q4	–	Sell	-41,400	Closed	-$1.43M	–	5374
2016 Q3	$1.43M	Buy	41,400 +3,700	+10%	+$79.4K	0.01%	1554
2016 Q2	$568K	Buy	+37,700	New	+$551K	﹤0.01%	2109